Deschutes Portfolio Strategy »

Rhythm Pharmaceuticals shares owned by Deschutes Portfolio Strategy

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Deschutes Portfolio Strategy from 13F filings

Historical chart of Deschutes Portfolio Strategy investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Deschutes Portfolio Strategy consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Deschutes Portfolio Strategy

Quarter filed Position value Share count Share price at filing
2026-06-30 $444k 4.0k 111.03
2020-06-30 $204k 9.1k 22.34

More positions owned by Deschutes Portfolio Strategy

Apple (AAPL)
Ishares Tr Core Div Grwth (DGRO)
Lam Research Corp Com New (LRCX)
Pimco CA Municipal Income Fund (PCQ)
Ascendis Pharma A/s Ord Shs (ASND)
Taiwan Fund (TWN)
Fs Credit Opportunities Corp Common Stock (FSCO)
Korea Com New (KF)
Xai Floating Rate & Alter In Com Shs Benf Int (XFLT)
Fs Specialty Lending Com Sh Ben Int (FSSL)
Microsoft Corporation (MSFT)
Nexpoint Diversified Rel Et Com New (NXDT)
Alphabet Cap Stk Cl A (GOOGL)
Highland Opps & Income Highland Income (HFRO)
Pimco NY Muni Income Fund II (PNI)

View all positions for Deschutes Portfolio Strategy

Top funds holding Rhythm Pharmaceuticals

RA Capital Management
BlackRock
Baker Bros. Advisors
PRIMECAP Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Jpmorgan Chase & Co
Perceptive Advisors
State Street Corporation
Westfield Capital Management Company
Goldman Sachs Group
Federated Investors
Polar Capital Holdings
T. Rowe Price Associates
Geode Capital Management

View all funds holding Rhythm Pharmaceuticals